Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work begins

MADRID — In a tes­ta­ment to clin­i­cians’ in­ter­est in Mer­ck and Mod­er­na’s per­son­al­ized can­cer vac­cine da­ta at this year’s Eu­ro­pean So­ci­ety for Med­ical On­col­o­gy con­fer­ence, the ... ...